Filter
995
Filtered Results: 995
Text search:
Pharmaceuticals
and
Supply
Agency
Featured
Recommendations
90
New Publications
304
Language
Document type
No document type
546
Studies & Reports
188
Guidelines
133
Strategic & Response Plan
54
Manuals
46
Training Material
10
Situation Updates
8
Fact sheets
7
Resource Platforms
3
Countries / Regions
Ethiopia
63
Kenya
43
Global
36
Nigeria
34
India
32
Liberia
26
Western and Central Europe
25
Uganda
22
Sierra Leone
18
Ghana
17
Malawi
17
Ukraine
16
Bangladesh
16
Zambia
16
Tanzania
15
Nepal
13
Syria
13
Namibia
13
Rwanda
12
Philippines
11
Africa
11
South Africa
11
Indonesia
11
Myanmar / Burma
10
Zimbabwe
9
Cambodia
9
Eastern Europe
9
Congo, Democratic Republic of
8
South–East Asia Region
7
Lesotho
6
Senegal
6
Botswana
6
South Sudan
6
Eswatini/ Swaziland
6
Guinea
5
Haiti
5
Eastern Europe and Central Asia
5
Burkina Faso
4
Latin America and the Carribbean
4
West and Central Africa
4
East and Southern Africa
4
Papua New Guinea
4
North Macedonia
3
Benin
3
Mozambique
3
Asia
3
Venezuela
3
Sudan
3
Pakistan
3
Tajikistan
2
Cameroon
2
Albania
2
Laos
2
Afghanistan
2
Jordan
2
Middle East and North Africa
2
Jamaica
2
United Kingdom
2
Lebanon
2
Moldova
2
Iraq
2
Thailand
1
Serbia
1
Australia
1
Kazakhstan
1
Kyrgyzstan
1
Niger
1
Uzbekistan
1
Bulgaria
1
Armenia
1
USA
1
Gabon
1
Denmark
1
Maldives
1
Brazil
1
Russia
1
Egypt
1
Yemen
1
Palestine
1
Georgia
1
Central African Republic
1
Mali
1
Angola
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
458
Key Resources
72
Clinical Guidelines
57
Public Health
35
Women & Child Health
24
Pharmacy & Technologies
21
Capacity Building
9
Toolboxes
Pharmacy
86
AMR
80
COVID-19
64
TB
48
HIV
43
Rapid Response
31
Mental Health
31
NTDs
30
Conflict
30
Planetary Health
26
Health Financing Toolbox
16
Caregiver
15
Global Health Education
15
Ebola & Marburg
13
Specific Hazards
11
Refugee
10
NCDs
10
Natural Hazards
8
Disability
4
Polio
4
Cholera
2
South Sudan
1
Social Ethics
1
Zika
1
"This document has been developed for outpatient oncology
facilities to serve as a model for a basic infection
control and prevention plan. It contains policies
and procedures tailored to these settings to meet minimal
expectations of patient protections as described
in the CDC Guide to Infecti...
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
NAMI HelpLine
Contents
I’m having a lot of anxiety because of the coronavirus. Please help.
I’m quarantined or working from home – lonely and isolated even further – what can I do?
I don’t have health insurance or a regular doctor – how can I get care?
What if I’m quarantin...
Lancet Psychiatry 2016;3: 415–24
R4D conducted a thorough desk review and qualitative fiscal space analysis, 19 interviews about financing for the three diseases and the extent of alignment between public financial management systems and health policy objectives, and a validation workshop with government officials.
Tanzania’...
Tanzania’...
Successful detonation of an improvised nuclear device (IND) would be a catastrophic event, causing an unprecedented number of injuries and lives lost, as well as economic, political, and social disruption. However, an effective medical response and an infrastructure prepared to protect itself from f...
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent disruption to health system functioning, reconstruction of the health system is integral to the country...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
